Cytosorbents Corp
CTSO
82 hedge funds and large institutions have $76.8M invested in Cytosorbents Corp in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 11 closing their positions.
123% more capital invested
Capital invested by funds: $34.4M → $76.8M (+$42.4M)
109% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 11
39% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 18
14% more funds holding
Funds holding: 72 → 82 (+10)
5% more call options, than puts
Call options by funds: $971K | Put options by funds: $925K
0.82% more ownership
Funds ownership: 27.58% → 28.4% (+0.82%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$1.57M |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$1.03M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$687K |
| 4 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$631K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$507K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$594K |
| 2 |
Two Sigma Investments
New York
|
-$418K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$287K |
| 4 |
D.E. Shaw & Co
New York
|
-$195K |
| 5 |
JP Morgan Chase
New York
|
-$154K |
CTSO Hedge Fund Activity: Q1 2020 in Review
82 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2020, worth a combined $76.8M — up 123% from $34.4M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new CTSO positions and 11 closed out — a net gain of 12 holders — while 25 added to existing stakes and 18 trimmed.
The largest buyer was Skylands Capital, adding an estimated $1.57M. The largest seller was Morgan Stanley, cutting an estimated $594K.
- 82 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2020, up from 72 in Q4 2019.
- Funds reported $76.8M of Cytosorbents Corp stock for Q1 2020, up 123% quarter-over-quarter.
- 23 funds opened new Cytosorbents Corp positions in Q1 2020 and 11 closed out, a net change of +12 holders.
- The largest Cytosorbents Corp buyer in Q1 2020 was Skylands Capital, an estimated $1.57M added.
- The largest Cytosorbents Corp seller in Q1 2020 was Morgan Stanley, an estimated $594K sold.
Based on aggregated 13F filings for Q1 2020.